NCT05156996 - A Prospective Real-World Multi-Center Post-Market Observational Evaluation of Supersaturated O2 Therapy Using the TherOx® Downstream® System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 4, 2022

Primary Completion Date

January 4, 2024

Study Completion Date

April 24, 2024

Conditions

Anterior Acute Myocardial Infarction (AMI)

Interventions

DEVICE

Supersaturated O2 Therapy of the Therox Downstream System®

SuperSaturated Oxygen Therapy (SSO2 Therapy) to targeted ischemic regions perfused by the patient's left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within 6 hours after the onset of anterior myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.

PROCEDURE

PCI alone

Percutaneous Coronary Intervention for treatment of acute MI

Trial Locations (2)

25304

Charleston Area Medical Center, Charleston

25702

St. Mary's Medical Center, Huntington